Health Highlights: March 28, 2022

Stakes are high ahead of FDA panel vote on ALS drug. Advocacy groups are pressing the agency to fast-track approval of an experimental drug treatment for the deadly neurological disease. But are regulators moving too fast? Read more Second COVID-19...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news